Explaining the Fifth Circuit Court of Appeals Ruling on Mifepristone Access

JAMA. 2023 Dec 5;330(21):2047-2048. doi: 10.1001/jama.2023.21591.
No abstract available

Plain language summary

This Viewpoint summarizes the Fifth Circuit Court of Appeals ruling on access to mifepristone, the first of 2 pills used in medication abortion.

MeSH terms

  • Abortifacient Agents* / therapeutic use
  • Abortion, Induced* / legislation & jurisprudence
  • Abortion, Induced* / methods
  • Family Planning Services* / legislation & jurisprudence
  • Female
  • Health Services Accessibility* / legislation & jurisprudence
  • Humans
  • Mifepristone* / therapeutic use
  • Pregnancy
  • United States

Substances

  • Mifepristone
  • Abortifacient Agents